CRISPR Therapeutics

ISIN CH0334081137

 | 

WKN A2AT0Z

Market cap (in EUR)
4,180 m
Country
Switzerland
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Switzerland

Données financières

Indicateurs clés

Capitalisation boursière, EUR 4,180 m
BPA, EUR -5.77
Ratio cours/valeur comptable 2.5
PER -
Rendement en dividendes 0.00%

Income statement (2025)

Chiffre d'affaires, EUR 3 m
Résultat net, EUR -516 m
Marge bénéficiaire -16,569.77%

What ETF is CRISPR Therapeutics in?

There are 4 ETFs which contain CRISPR Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of CRISPR Therapeutics is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Poids Objectif d'investissement Taille fonds en M €
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.37%
Equity
United States
Health Care
Biotech
46
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
508
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
25
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.07%
Equity
United States
Small Cap
202
— Les données utilisées sont mises à disposition par Trackinsight, etfinfo, Xignite Inc., gettex, FactSet et justETF GmbH.

Les cotations sont des cotations en temps réel (gettex), des cotations boursières retardées de 15 minutes ou des VNI (quotidiennes publiées par le fournisseur du fonds). Par défaut, les rendements des ETF incluent les paiements de dividendes (le cas échéant). Aucune garantie n'est donnée quant à l'exhaustivité, la précision et l'exactitude des informations affichées.